Financial reports
10-Q
2022 Q3
Quarterly report
9 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
10-Q
2022 Q1
Quarterly report
11 May 22
10-K
2021 FY
Annual report
25 Mar 22
10-K/A
2020 FY
Annual report (amended)
31 Jan 22
10-Q
2021 Q3
Quarterly report
9 Nov 21
10-Q
2021 Q2
Quarterly report
9 Aug 21
10-Q
2021 Q1
Quarterly report
24 May 21
10-K/A
2020 FY
Annual report (amended)
24 May 21
Current reports
8-K
Entry into a Material Definitive Agreement
23 Nov 22
8-K
Submission of Matters to a Vote of Security Holders
15 Nov 22
8-K/A
NewAmsterdam Pharma Holding B.V. and Frazier Lifesciences Acquisition Corporation Announce Merger
25 Jul 22
8-K
NewAmsterdam Pharma Holding B.V. and Frazier Lifesciences Acquisition Corporation Announce Merger
25 Jul 22
8-K
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
26 Jan 22
8-K
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
24 May 21
8-K
Frazier Lifesciences Acquisition Corporation Securities to Commence Separate Trading
29 Jan 21
8-K
Frazier Lifesciences Acquisition Corporation
17 Dec 20
8-K
Frazier Lifesciences Acquisition Corporation Announces Pricing of Upsized $120 Million Initial Public Offering
14 Dec 20
Registration and prospectus
15-12G
Securities registration termination
2 Dec 22
25-NSE
Exchange delisting
22 Nov 22
25-NSE
Exchange delisting
22 Nov 22
25-NSE
Exchange delisting
22 Nov 22
425
Business combination disclosure
16 Nov 22
425
Business combination disclosure
17 Oct 22
425
Business combination disclosure
13 Oct 22
425
Business combination disclosure
11 Oct 22
425
Business combination disclosure
5 Oct 22
425
Business combination disclosure
5 Oct 22
Other
UPLOAD
Letter from SEC
19 Aug 22
CORRESP
Correspondence with SEC
18 Aug 22
UPLOAD
Letter from SEC
2 Aug 22
EFFECT
Notice of effectiveness
9 Dec 20
CERT
Certification of approval for exchange listing
7 Dec 20
CORRESP
Correspondence with SEC
4 Dec 20
CORRESP
Correspondence with SEC
4 Dec 20
CORRESP
Correspondence with SEC
20 Nov 20
Ownership
SC 13G/A
Alyeska Investment Group, L.P.
15 Feb 23
SC 13G/A
Flynn James E
1 Dec 22
SC 13D/A
VIKING GLOBAL INVESTORS LP
25 Nov 22
4
OLE ANDREAS HALVORSEN
25 Nov 22
4
David Joseph Topper
23 Nov 22
4
MICHAEL BIGHAM
23 Nov 22
4
Krishna R Polu
23 Nov 22
4
Robert Jr. Baltera
23 Nov 22
4
Carol Giltner Gallagher
23 Nov 22
SC 13D/A
Frazier Lifesciences Sponsor LLC
23 Nov 22